Bio-Techne (TECH) Short Interest Ratio & Short Volume → What is Medicare Supplement Insurance? (From Tranzact) (Ad) Free TECH Stock Alerts $62.66 -0.86 (-1.35%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Bio-Techne Short Interest DataCurrent Short Volume5,750,000 sharesPrevious Short Volume5,320,000 sharesChange Vs. Previous Month+8.08%Dollar Volume Sold Short$376.74 millionShort Interest Ratio / Days to Cover5.4Last Record DateApril 15, 2024Outstanding Shares157,190,000 sharesPercentage of Shares Shorted3.66%Today's Trading Volume965,762 sharesAverage Trading Volume928,335 sharesToday's Volume Vs. Average104% Short Selling Bio-Techne ? Sign up to receive the latest short interest report for Bio-Techne and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatTECH Short Interest Over TimeTECH Days to Cover Over TimeTECH Percentage of Float Shorted Over Time Ad Colonial MetalsThe Gold Grab of the CenturyWhen central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. Bio-Techne Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20245,750,000 shares $376.74 million +8.1%N/A5.4 $65.52 3/31/20245,320,000 shares $374.47 million +4.3%N/A5 $70.39 3/15/20245,100,000 shares $369.85 million +11.4%N/A4.9 $72.52 2/29/20244,580,000 shares $336.95 million -3.2%N/A4.2 $73.57 2/15/20244,730,000 shares $337.06 million +42.5%N/A4.4 $71.26 1/31/20243,320,000 shares $233.46 million -17.8%N/A2.9 $70.32 Get the Latest News and Ratings for TECH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bio-Techne and its competitors with MarketBeat's FREE daily newsletter. 1/15/20244,040,000 shares $291.57 million -17.2%N/A3.3 $72.17 12/31/20234,880,000 shares $376.54 million -2.8%N/A4.1 $77.16 12/15/20235,020,000 shares $381.47 million +39.1%N/A4.2 $75.99 11/30/20233,610,000 shares $227.07 million +24.5%N/A3.2 $62.90 11/15/20232,900,000 shares $176.58 million -10.5%N/A2.7 $60.89 10/31/20233,240,000 shares $177.00 million -5.0%N/A3.2 $54.63 10/15/20233,410,000 shares $231.16 million -7.8%N/A4 $67.79 9/30/20233,700,000 shares $251.86 million +7.6%N/A4.5 $68.07 9/15/20233,440,000 shares $253.36 million +11.0%N/A4.2 $73.65 8/31/20233,100,000 shares $243.04 million -1.3%N/A3.6 $78.40 8/15/20233,140,000 shares $265.68 million +7.2%N/A3.6 $84.61 7/31/20232,930,000 shares $244.36 million -7.0%N/A3.2 $83.40 7/15/20233,150,000 shares $265.29 million +14.1%N/A3.2 $84.22 6/30/20232,760,000 shares $225.30 million -8.0%N/A2.6 $81.63 6/15/20233,000,000 shares $229.83 million -1.3%N/A2.8 $76.61 5/31/20233,040,000 shares $248.64 million +1.3%N/A3 $81.79 5/15/20233,000,000 shares $243.24 million +7.9%N/A2.8 $81.08 4/30/20232,780,000 shares $222.07 million -25.9%N/A2.6 $79.88 4/15/20233,750,000 shares $319.65 million +55.6%N/A3.6 $85.24 3/31/20232,410,000 shares $178.80 million -6.6%N/A2.4 $74.19 3/15/20232,580,000 shares $187.75 million +0.8%N/A2.7 $72.77 2/28/20232,560,000 shares $185.96 million +16.4%N/A2.6 $72.64 2/15/20232,200,000 shares $168.96 million -19.1%N/A2.3 $76.80 1/31/20232,720,000 shares $216.68 million +19.3%N/A2.6 $79.66 1/15/20232,280,000 shares $184.34 million -3.4%N/A2.1 $80.85 12/30/20222,360,000 shares $195.60 million -3.7%N/A2.2 $82.88 12/15/20222,450,000 shares $206.27 million +3.8%N/A2 $84.19 11/30/20222,360,000 shares $200.58 million +210.1%N/A1.9 $84.99 11/15/2022761,100 shares $268.13 million +9.4%2.0%2.5 $352.29 10/31/2022695,500 shares $206.05 million +2.8%1.8%2.4 $296.26 10/15/2022676,500 shares $191.35 million -3.1%1.8%2.7 $282.86 9/30/2022697,900 shares $198.20 million -0.4%1.8%2.8 $284.00 9/15/2022700,500 shares $221.62 million +25.0%1.8%3.3 $316.37 8/31/2022560,400 shares $185.95 million +1.6%1.5%2.5 $331.81These AI trades triggered this morning (545% return) (Ad)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy TECH Short Interest - Frequently Asked Questions What is Bio-Techne's current short interest? Short interest is the volume of Bio-Techne shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 5,750,000 shares of TECH short. Learn More on Bio-Techne's current short interest. What is a good short interest ratio for Bio-Techne? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TECH shares currently have a short interest ratio of 5.0. Learn More on Bio-Techne's short interest ratio. Which institutional investors are shorting Bio-Techne? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Bio-Techne: PEAK6 Investments LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Bio-Techne's short interest increasing or decreasing? Bio-Techne saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 5,750,000 shares, an increase of 8.1% from the previous total of 5,320,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Bio-Techne's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Bio-Techne: Teleflex Incorporated (1.51%), Catalent, Inc. (3.97%), Tenet Healthcare Co. (3.93%), Repligen Co. (8.85%), Qiagen (1.34%), Henry Schein, Inc. (4.14%), Chemed Co. (2.96%), Smith & Nephew plc (0.48%), Natera, Inc. (4.77%), Sarepta Therapeutics, Inc. (5.19%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Bio-Techne stock? Short selling TECH is an investing strategy that aims to generate trading profit from Bio-Techne as its price is falling. TECH shares are trading down $0.86 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Bio-Techne? A short squeeze for Bio-Techne occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TECH, which in turn drives the price of the stock up even further. How often is Bio-Techne's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TECH, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Teleflex Short Squeeze Catalent Short Squeeze Tenet Healthcare Short Squeeze Repligen Short Squeeze Qiagen Short Squeeze Henry Schein Short Squeeze Chemed Short Squeeze Smith & Nephew Short Squeeze Natera Short Squeeze Sarepta Therapeutics Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TECH) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersI’m afraid WWIII is a very real possibility Porter & Company